EUDA Health Repurchases Streeterville Warrant and Amends Charter to Clarify Share Actions

EUDA Health Holdings ( (EUDA) ) has issued an announcement.

EUDA Health Holdings Limited, a Singapore-based non-invasive healthcare provider focused on Singapore, Malaysia and China, is positioning itself as a regional leader in preventive and longevity-focused healthcare while also operating a property management business in Singapore. The company aims to address the needs of an aging population of more than 1.8 billion people across Asia by delivering innovative and accessible health solutions.

On February 27, 2026, EUDA Health filed an amended and restated charter in the British Virgin Islands to clarify its ability to divide or combine ordinary shares via board or shareholder resolutions. On the same day, the company repurchased for US$125,000 and cancelled in full a Streeterville Capital warrant for up to 2,000,000 ordinary shares, eliminating potential dilution under that agreement and signaling a move to simplify its capital structure ahead of recent securities filings and market communications in early March 2026.

The most recent analyst rating on (EUDA) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on EUDA Health Holdings stock, see the EUDA Stock Forecast page.

More about EUDA Health Holdings

EUDA Health Holdings Limited is a Singapore-based provider of non-invasive and preventive healthcare services across Asia, with a primary focus on Singapore, Malaysia and China. The company targets the fast-growing longevity sector by offering science-backed, accessible solutions aimed at shifting regional healthcare from reactive treatment to proactive, longevity-focused care, and it also operates a Singapore-based property management business.

Average Trading Volume: 531,070

Technical Sentiment Signal: Sell

Current Market Cap: $29.77M

For an in-depth examination of EUDA stock, go to TipRanks’ Overview page.